university of illinois - UIHistories Project

1038 BOARD OF TRUSTEES [December 17
238. Ames Research Laboratories, Elkhart, Indiana: to the Department
of Clinical Science for a study of choleretic action of various
synthetic chemical compounds compared with decholin, under the
supervision of Dr. Andrew C. Ivy 2 533 35
239. Armour Laboratories, Kankakee, Illinois: to the Department of
Pharmacology for travel expenses for scientists who are invited
to conduct seminars for the department 500 00
240. Bauer and Black, Chicago: to the Department of Clinical Science
for a study of cholesterol synthesis in rats, under the direction of
Dr. Andrew C. Ivy I 050 00
241. Baxter Laboratories, Chicago: to the Department of Microbiology
for research on the evaluation of potential chemotherapeutic agents,
under the direction of Dr. George H. Scherr 774 90
242. Ciba Pharmaceutical Products, Inc., Summit, New Jersey: to the
Department of Anatomy for a study of reserpine stress responses,
under the direction of Dr. Samuel R. M. Reynolds 900 00
243. Dome Chemicals, Inc., New York, New York: to the Department
of Dermatology for research under the direction of Dr. Marcus R.
Caro 500 00
244. E and J Manufacturing Company, Burbank, California: to the Department
of Clinical Science to supplement a previous grant to
cover expenses for an exhibit on cardio-respiratory dynamics of
controlled respiration prepared for the American Medical Association
convention, under the direction of Dr. Archer S. Gordon 873 00
245. Geigy Pharmaceuticals, Ardsley, New York: to the Department of
Pharmacology for a study of action of autonomic drugs on the central
nervous system, under the direction of Dr. Klaus R. W. Unna 7 315 00
246. Hoffman-LaRoche, Inc., Nutley, New Jersey 3 553 50
To the Department of Surgery (Anesthesiology) for a
study of the comparative evaluation of pentobarbital and
noludar, under the supervision of Dr. Max S. Sadove
and Dr. Reuben C. Balagot $ 2 000 00
To the Department of Clinical Science for a study of the
effect of marsilid on gastric secretion in dog, under the
direction of Dr. Andrew C. Ivy I 553 50
247. Lederle Laboratories, Pearl River, New York: to the
Graduate College for fellowships for medical students,
under the supervision of Dr. Milan V. Novak 2 400 00
248. EH Lilly and Company, Indianapolis, Indiana 5 588 75
To the College of Medicine for research on protein
synthesis in virus infections, under the direction of Dr.
John E. Kempf $5 290 00
To the Department of Clinical Science for an exploratory
study of the effect of phenaglycodal (ultran) on
gastric secretion, under the direction of Dr. Andrew C.
Ivy 298 75
249. Mead-Johnson and Company, Chicago: to the Department of
Pediatrics for pediatric residents, under the direction of Dr.
Heyworth N. Sanford 500 00
250. Organon, Inc., Orange, New Jersey: to the Department of Physiology
for an investigation of properties of a new hypertensive
agent, under the direction of Dr. George E. Wakerlin 500 00
251. Chas. F. Pfizer and Company, Inc., Brooklyn, New York: to the
Department of Medicine for work of investigative nature in infectious
diseases and related fields, under the direction of Dr. Harry
F. Dowling 600000
252. Sandoz Pharmaceuticals, Chicago 8 925 00
To the Department of Pharmacology for the neuropharmacology
research fund, under the direction of Dr.
Klaus R. W. Unna $3 000 00
To the Department of Medicine to support student assistants
for studies in experimental and clinical allergy,
under the supervision of Dr. Max Samter 3 000 00